CIK: 0001281446 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 14, 2019
Total Value ($000): $1,010,320 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS INC | 1,814,260 | $68,289 | 6.8% | $27.49 | +22.1% | COM | 69366J200 |
| — | ZOGENIX INC | 1,199,545 | $65,987 | 6.5% | $39.55 | — | COM | 98978L204 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 1,180,000 | $62,457 | 6.2% | $41.05 | — | COM | 37890U108 |
| — | AUDENTES THERAPEUTICS INC | 1,572,618 | $61,364 | 6.1% | $21.32 | — | COM | 05070R104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,000,000 | $53,700 | 5.3% | $18.73 | +24.7% | COM | 004225108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 5,567,348 | $52,945 | 5.2% | $9.91 | -2.0% | COM | 462260100 |
| — | ACCELERON PHARMA INC | 1,080,113 | $50,301 | 5.0% | $10499.23 | — | COM | 00434H108 |
| ASND | ASCENDIS PHARMA AS | 415,000 | $48,846 | 4.8% | $117.70 | — | SPONSORED ADR | 04351P101 |
| BCRX | BIOCRYST PHARMACEUTICALS | 5,955,762 | $48,480 | 4.8% | $5.12 | +67.3% | COM | 09058V103 |
| — | INTERCEPT PHARMACEUTICALS INC | 400,000 | $44,744 | 4.4% | — | — | Put | 45845P108 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 379,832 | $44,581 | 4.4% | $115.96 | +0.5% | COM | 91307C102 |
| — | ARRAY BIOPHARMA INC | 1,800,000 | $43,884 | 4.3% | $14.25 | — | COM | 04269X105 |
| KURA | KURA ONCOLOGY INC | 2,645,100 | $43,882 | 4.3% | $12.07 | +27.7% | COM | 50127T109 |
| PBYI | PUMA BIOTECHNOLOGY INC | 900,000 | $34,911 | 3.5% | $30.01 | +1.8% | COM | 74587V107 |
| — | FIVE PRIME THERAPEUTICS INC | 2,398,409 | $32,139 | 3.2% | $6226.03 | — | COM | 33830X104 |
| GNFTY | GENFIT SA | 1,230,314 | $29,528 | 2.9% | $24.00 | — | ADS | 372279109 |
| — | EPIZYME INC | 2,173,913 | $26,935 | 2.7% | $12.39 | — | COM | 29428V104 |
| ASND | ASCENDIS PHARMA AS | 200,000 | $23,540 | 2.3% | $117.70 | — | Put | 04351P101 |
| — | DERMIRA INC | 1,500,000 | $20,325 | 2.0% | $13.55 | — | COM | 24983L104 |
| — | MILLENDO THERAPEUTICS INC | 1,288,093 | $19,321 | 1.9% | $7.95 | — | COM | 60040X103 |
| KRYS | KRYSTAL BIOTECH INC | 492,100 | $16,190 | 1.6% | $20.94 | +12.6% | COM | 501147102 |
| — | MENLO THERAPEUTICS INC | 2,057,027 | $16,148 | 1.6% | $7.51 | — | COM | 586858102 |
| — | CYMABAY THERAPEUTICS INC | 998,841 | $13,265 | 1.3% | $7.87 | — | COM | 23257D103 |
| — | FIBROGEN INC | 200,000 | $10,870 | 1.1% | — | — | Put | 31572Q808 |
| CTMX | CYTOMX THERAPEUTICS INC | 959,077 | $10,310 | 1.0% | $14.78 | 0.0% | COM | 23284F105 |
| — | BIOHAVEN PHARMACTL HLDG CO | 200,000 | $10,294 | 1.0% | — | — | Put | G11196105 |
| — | FOAMIX PHARMACEUTICALS LTD | 2,697,133 | $10,114 | 1.0% | $7.50 | — | SHS | M46135105 |
| — | ZAFGEN INC | 3,110,874 | $8,524 | 0.8% | $9.93 | — | COM | 98885E103 |
| — | DERMIRA INC | 555,300 | $7,524 | 0.7% | $13.55 | — | Put | 24983L104 |
| RVLPQ | OSMOTICA PHARMACEUTICALS PLC | 1,500,000 | $5,400 | 0.5% | $8.00 | -8.0% | SHS | G6S41R101 |
| — | ARRAY BIOPHARMA INC | 200,000 | $4,876 | 0.5% | $14.25 | — | Call | 04269X105 |
| SVRA | SAVARA INC | 660,366 | $4,867 | 0.5% | $11.29 | -33.2% | COM | 805111101 |
| — | MOMENTA PHARMACEUTICALS INC | 309,564 | $4,498 | 0.4% | $14.53 | — | COM | 60877T100 |
| — | PROTEOSTASIS THERAPEUTICS INC | 3,500,000 | $4,410 | 0.4% | $2.98 | — | COM | 74373B109 |
| — | NOVAVAX INC | 4,500,000 | $2,479 | 0.2% | — | — | Call | 670002104 |
| — | SOLID BIOSCIENCES INC | 200,000 | $1,840 | 0.2% | — | — | Call | 83422E105 |
| — | NOVAVAX INC | 2,000,000 | $1,102 | 0.1% | — | — | Put | 670002104 |
| AKBA | AKEBIA THERAPEUTICS INC | 131,531 | $1,077 | 0.1% | $6.86 | 0.0% | COM | 00972D105 |
| — | ZYMEWORKS INC | 14,610 | $236 | 0.0% | $16.15 | — | COM | 98985W102 |
| — | STREAMLINE HEALTH SOLUTIONS | 130,137 | $137 | 0.0% | $6.45 | — | COM | 86323X106 |